Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
Young Hee Ko(Johns Hopkins University), Peter L. Pedersen(Johns Hopkins University), Martin G. Pomper(Southwestern Medical Center), Barbara L. Smith(Harvard University), Michael Torbenson(Mayo Clinic), Joanne Hullihen(Johns Hopkins University), Yuchuan Wang(Johns Hopkins University), David Rini(Johns Hopkins University)
Cited by 350
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Ion motive ATPases. I. Ubiquity, properties, and significance to cell function
|Trends in Biochemical Sciences|1987|966
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
|Oncogene|2006|756
Tumor Mitochondria and the Bioenergetics of Cancer Cells
|Progress in tumor research|2015|715
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.
|Journal of Biological Chemistry|1986|691